双盲假对照随机试验:fMRI神经反馈对ADHD儿童临床与认知指标无效
该双盲假对照随机试验在88名ADHD男孩中测试右侧额下回fMRI神经反馈的疗效,主要结局ADHD-RS评分在治疗后无显著组间差异,两组其他临床与认知指标也类似下降,仅假对照组在易激惹和运动抑制上改善更明显,未发现显著副作用。
要点
- fMRI神经反馈未显著改善ADHD症状或认知功能。
- 假对照组在易激惹和运动抑制上改善更明显。
- 无显著副作用或不良事件,但无学习迁移。
核心结论
- fMRI神经反馈对右侧额下回的训练未能有效改善ADHD男孩的临床症状或认知功能,结果与假设相反。
研究设计与样本
- 双盲假对照随机对照试验,纳入88名ADHD男孩,活性组与假组各44人,比较治疗后和6个月随访时的组间差异。
主要发现
- 主要结局ADHD-RS评分在治疗后无显著组间差异。
- 两组在其他临床和认知指标上均出现类似下降。
- 治疗后假对照组在易激惹下降和运动抑制改善上显著优于活性组。
- 无显著副作用或不良事件。
- 活性组右侧额下回及其他额叶、颞枕小脑自我调节区域激活增强,但无右侧额下回进行性上调、与ADHD-RS评分无相关、无学习迁移。
关键数值与推荐
- 主要结局为治疗后ADHD评分量表(ADHD-RS)得分。
- 分析控制基线评分、年龄和用药状态。
临床怎么用
- 目前证据不支持将右侧额下回fMRI神经反馈用于ADHD男孩的临床治疗。
- 临床决策时应考虑其他有证据支持的治疗方法。
局限性
- 仅纳入男孩,结果不能推广至女孩。
- 样本量有限,可能影响统计效能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Functional MRI neurofeedback (fMRI-NF) could potentially be a novel, safe nonpharmacological treatment for attention deficit hyperactivity disorder (ADHD). A proof-of-concept randomized controlled trial of fMRI-NF of the right inferior frontal cortex (rIFC), compared to an active control condition, showed promising improvement of ADHD symptoms (albeit in both groups) and in brain function. However, comparison with a placebo condition in a larger trial is required to test efficacy. METHODS: This double-blind, sham-controlled randomized controlled trial tested the effectiveness and efficacy of fMRI-NF of the rIFC on symptoms and executive functions in 88 boys with ADHD (44 each in the active and sham arms). To investigate treatment-related changes, groups were compared at the posttreatment and 6-month follow-up assessments, controlling for baseline scores, age, and medication status. The primary outcome measure was posttreatment score on the ADHD Rating Scale (ADHD-RS). RESULTS: No significant group differences were found on the ADHD-RS. Both groups showed similar decreases in other clinical and cognitive measures, except for a significantly greater decrease in irritability and improvement in motor inhibition in sham relative to active fMRI-NF at the posttreatment assessment, covarying for baseline. There were no significant side effects or adverse events. The active relative to the sham fMRI-NF group showed enhanced activation in rIFC and other frontal and temporo-occipital-cerebellar self-regulation areas. However, there was no progressive rIFC upregulation, correlation with ADHD-RS scores, or transfer of learning. CONCLUSIONS: Contrary to the hypothesis, the study findings do not suggest that fMRI-NF of the rIFC is effective in improving clinical symptoms or cognition in boys with ADHD.
引用
- Lam SL, Criaud M, Lukito S, et al. Double-Blind, Sham-Controlled Randomized Trial Testing the Efficacy of fMRI Neurofeedback on Clinical and Cognitive Measures in Children With ADHD. Am J Psychiatry. 2022. PMID: 36349428. doi:10.1176/appi.ajp.21100999
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。